Chase Investment Counsel Corp Syneos Health, Inc. Transaction History

Chase Investment Counsel Corp

  • $296 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020
SELL
$32.64 - $73.63 $298,003 - $672,241
-9,130 Closed
0 $0
Q4 2019

Feb 06, 2020
BUY
$48.0 - $59.55 $50,400 - $62,527
1,050 Added 13.0%
9,130 $543,000
Q3 2019

Oct 29, 2019
BUY
$46.64 - $55.39 $376,851 - $447,551
8,080 New
8,080 $429,000

Others Institutions Holding SYNH

# of Institutions
12
Shares Held
731K
Call Options Held
0
Put Options Held
0
View Full List

About Syneos Health, Inc.

SYNH Quotes by TradingView
  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email